"miravirsen" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-virsen",
        "t2": "antiviral antisense oligonucleotide"
      },
      "expansion": "[Term?] + -virsen (“antiviral antisense oligonucleotide”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -virsen (“antiviral antisense oligonucleotide”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "miravirsen (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -virsen",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 August 13, Merav Kedmi et al., “MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression”, in Journal of Clinical Medicine, volume 4, →DOI",
          "text": "Currently, miravirsen is applied in seven clinical trials, some are already in phase II.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "A locked nucleic acid-based antisense oligonucleotide with potential medical applications."
      ],
      "id": "en-miravirsen-en-noun-A-zJddYs",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "nucleic acid",
          "nucleic acid"
        ],
        [
          "antisense",
          "antisense"
        ],
        [
          "oligonucleotide",
          "oligonucleotide"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A locked nucleic acid-based antisense oligonucleotide with potential medical applications."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "word": "miravirsen"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-virsen",
        "t2": "antiviral antisense oligonucleotide"
      },
      "expansion": "[Term?] + -virsen (“antiviral antisense oligonucleotide”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -virsen (“antiviral antisense oligonucleotide”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "miravirsen (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English term requests",
        "English terms suffixed with -virsen",
        "English terms with quotations",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "examples": [
        {
          "ref": "2015 August 13, Merav Kedmi et al., “MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression”, in Journal of Clinical Medicine, volume 4, →DOI",
          "text": "Currently, miravirsen is applied in seven clinical trials, some are already in phase II.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "A locked nucleic acid-based antisense oligonucleotide with potential medical applications."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "nucleic acid",
          "nucleic acid"
        ],
        [
          "antisense",
          "antisense"
        ],
        [
          "oligonucleotide",
          "oligonucleotide"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A locked nucleic acid-based antisense oligonucleotide with potential medical applications."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "word": "miravirsen"
}